283 related articles for article (PubMed ID: 19073395)
21. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
22. [The antioxidative and inflammation inhibiting properties of ambroxol].
Winsel K
Pneumologie; 1992 Sep; 46(9):461-75. PubMed ID: 1438126
[No Abstract] [Full Text] [Related]
23. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
Siergiejko Z; Obrzut D; Rogalewska A
Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
[TBL] [Abstract][Full Text] [Related]
25. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
Kranicke R
Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
[TBL] [Abstract][Full Text] [Related]
26. The pharmacology of ambroxol--review and new results.
Disse BG
Eur J Respir Dis Suppl; 1987; 153():255-62. PubMed ID: 3322865
[TBL] [Abstract][Full Text] [Related]
27. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
28. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
Primbs K
Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
[TBL] [Abstract][Full Text] [Related]
29. [A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion].
Li W; Mao B; Wang G; Wang L; Chang J; Zhang Y; Wan MH; Guo J
Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):799-805. PubMed ID: 18664347
[TBL] [Abstract][Full Text] [Related]
30. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
[TBL] [Abstract][Full Text] [Related]
31. Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial.
Refai M; Brunelli A; Xiumé F; Salati M; Sciarra V; Socci L; Di Nunzio L; Sabbatini A
Eur J Cardiothorac Surg; 2009 Mar; 35(3):469-73. PubMed ID: 19144532
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.
de Mey C; Patel J; Lakha DR; Richter E; Koelsch S
Drug Res (Stuttg); 2015 Dec; 65(12):658-67. PubMed ID: 25782170
[TBL] [Abstract][Full Text] [Related]
33. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
34. Acebrophylline: an airway mucoregulator and anti-inflammatory agent.
Pozzi E
Monaldi Arch Chest Dis; 2007 Jun; 67(2):106-15. PubMed ID: 17695695
[TBL] [Abstract][Full Text] [Related]
35. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
Aliperta A; Bellissimo U; Turco D; Antinolfi G
Int J Tissue React; 1986; 8(2):167-74. PubMed ID: 2939036
[TBL] [Abstract][Full Text] [Related]
36. Biofilm-dependent airway infections: a role for ambroxol?
Cataldi M; Sblendorio V; Leo A; Piazza O
Pulm Pharmacol Ther; 2014 Aug; 28(2):98-108. PubMed ID: 24252805
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.
Simpson JL; Phipps S; Gibson PG
Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
40. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
Olivieri D; Del Donno M; Annicelli A; Palmieri F
Arch Monaldi; 1983; 38(4):135-40. PubMed ID: 6679252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
